Kirk Exner
Chief Executive Officer at AMEGO CAPITAL CORP.
Net worth: 117 964 $ as of 2024-06-29
Profile
Kirk Exner is currently the President, CEO, Secretary & Director at Amego Capital Corp.
He previously held the positions of President, CEO, CFO & Secretary at Ostrom Climate Solutions, Inc. and Interlude Capital Corp.
He was also an Independent Director at Venturi Ventures, Inc. from 2013 to 2014 and President at Newcoast Capital Corp.
Mr. Exner received his undergraduate degree from the University of British Columbia in 1990 and his MBA from The Schulich School of Business in 1992.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
AMEGO CAPITAL CORP.
13.70% | 2024-06-06 | 766,000 ( 13.70% ) | 117 964 $ | 2024-06-29 |
Kirk Exner active positions
Companies | Position | Start |
---|---|---|
AMEGO CAPITAL CORP. | Chief Executive Officer | 2021-07-06 |
Former positions of Kirk Exner
Companies | Position | End |
---|---|---|
Venturi Ventures, Inc.
Venturi Ventures, Inc. Medical SpecialtiesHealth Technology Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada. | Director/Board Member | 2014-08-26 |
Newcoast Capital Corp. | President | - |
OSTROM CLIMATE SOLUTIONS INC. | Chief Executive Officer | - |
Interlude Capital Corp. | Chief Executive Officer | - |
Training of Kirk Exner
University of British Columbia | Undergraduate Degree |
The Schulich School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
OSTROM CLIMATE SOLUTIONS INC. | Industrial Services |
AMEGO CAPITAL CORP. | Finance |
Private companies | 3 |
---|---|
Venturi Ventures, Inc.
Venturi Ventures, Inc. Medical SpecialtiesHealth Technology Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada. | Health Technology |
Interlude Capital Corp. | Finance |
Newcoast Capital Corp. |
- Stock Market
- Insiders
- Kirk Exner